Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis

BACKGROUND: Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC). However, the individual role of EGFR‐TKIs in patients with brain metastasis (BM) arising from EGFR‐mutant NSCLC remains unclear. M...

Full description

Saved in:
Bibliographic Details
Published in:Thorac Cancer
Main Authors: Zhang, Qiuyi, Zhang, Xuchao, Yan, Honghong, Jiang, Benyuan, Xu, Chongrui, Yang, Jinji, Chen, Zhihong, Su, Jian, Wu, Yi‐Long, Zhou, Qing
Format: Artigo
Language:Inglês
Published: John Wiley & Sons Australia, Ltd 2016
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093172/
https://ncbi.nlm.nih.gov/pubmed/27755835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12379
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items